Publications

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.

Van Minh, H; My, NT T; JIT, M;

2017

BMC health services research, (2017).17 1 10.1186/s12913-017-2297-x.

Semantic network analysis of vaccine sentiment in online social media.

Kang, GJ; Ewing-Nelson, SR; Mackey, L; Schlitt, JT; Marathe, A; ABBAS, KM; Swarup, S;

2017

Vaccine, (2017).35 29 10.1016/j.vaccine.2017.05.052.

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.

Cama, A; Müller, A; Taoaba, R; BUTCHER, RM R; Itibita, I; MIGCHELSEN, SJ; Kiauea, T; PICKERING, H; Willis, R; ROBERTS, CH; Bakhtiari, A; Le Mesurier, RT; ALEXANDER, ND E; Martin, DL; Tekeraoi, R; Solomon, AW; Global Trachoma Mapping Project,;

2017

PLoS neglected tropical diseases, (2017).11 9 10.1371/journal.pntd.0005863.

Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.

Habib, MA; Soofi, S; COUSENS, S; Anwar, S; Haque, NU; Ahmed, I; Ali, N; Tahir, R; Bhutta, ZA;

2017

The Lancet Global health, (2017).5 6 10.1016/S2214-109X(17)30184-5.

Role of bacille Calmette-Guérin in preventing tuberculous infection.

Adinarayanan, S; Culp, RK; Subramani, R; ABBAS, KM; Radhakrishna, S; Swaminathan, S;

2017

The international journal of tuberculosis and lung disease, (2017).21 4 10.5588/ijtld.16.0833.

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.

CLARK, A; Tate, J; Parashar, U; JIT, M; Hasso-Agopsowicz, M; Henschke, N; Lopman, B; VAN ZANDVOORT, K; Pecenka, C; FINE, P; SANDERSON, C;

2017

The Lancet Global Health, (2017).7 11 10.1016/S2214-109X(19)30412-7.

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.

WAJJA, A; Kizito, D; Nassanga, B; NALWOGA, A; Kabagenyi, J; Kimuda, S; Galiwango, R; Mutonyi, G; Vermaak, S; Satti, I; Verweij, J; Tukahebwa, E; COSE, S; Levin, J; KALEEBU, P; ELLIOTT, AM; McShane, H;

2017

PLoS neglected tropical diseases, (2017).11 5 10.1371/journal.pntd.0005440.

Facilitators and barriers of parental attitudes and beliefs toward school-located influenza vaccination in the United States: Systematic review.

Kang, GJ; Culp, RK; ABBAS, KM;

2017

Vaccine, (2017).35 16 10.1016/j.vaccine.2017.03.014.

Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.

Neuzil, KM; Bresee, JS; De la Hoz, F; Johansen, K; Karron, RA; Krishnan, A; Madhi, SA; MANGTANI, P; Spiro, DJ; Ortiz, JR; WHO Preferred Product Characteristics for Next-Gen,;

2017

Vaccine, (2017).35 43 10.1016/j.vaccine.2017.08.088.

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine.

GREENWOOD, B; Dicko, A; Sagara, I; Zongo, I; Tinto, H; CAIRNS, M; KUEPFER, I; MILLIGAN, P; Ouedraogo, J-B; Doumbo, O; CHANDRAMOHAN, D;

2017

Malaria journal, (2017).16 1 10.1186/s12936-017-1841-9.